Phenobarbital NDC 75826-136

NDC codes

FDA NDC Directory

Product NDC (as listed)75826-136Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75826-0136Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75826-136-10	75826013610	100 TABLET in 1 BOTTLE, PLASTIC (75826-136-10)Marketed from Oct 1, 2018
75826-136-50	75826013650	500 TABLET in 1 BOTTLE, PLASTIC (75826-136-50)Marketed from Nov 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phenobarbital
Generic name (nonproprietary): phenobarbital
Active ingredients: Phenobarbital — 15 mg/1
Dosage form: Tablet
Route: Oral
Labeler: WINDER LABORATORIES, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Oct 1, 2018
Listing expires: Dec 31, 2026
DEA schedule: CIV
Identifiers: Product ID 75826-136_2b0ed16e-a65d-bed5-e063-6394a90aa05eSPL ID 2b0ed16e-a65d-bed5-e063-6394a90aa05eSPL set ID 1805bc08-e870-4373-b290-bed1eed87df6RxCUI 198083, 198086, 198089, 199164, 199167, 199168, 312357, 312362UNII YQE403BP4DUPC 0375826140101, 0375826143102

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475826013610 followed by a unit qualifier and the quantity

Package 75826-0136-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 31, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Phenobarbital Tablets, USP are indicated for use as a sedative or anticonvulsant.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)